TY - JOUR
T1 - Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1 +) presenting as subfulminant hepatitis
AU - Ben-Ari, Ziv
AU - Broida, Effrat
AU - Monselise, Yehudit
AU - Kazatsker, Anna
AU - Baruch, Jacob
AU - Pappo, Orit
AU - Skappa, Eitan
AU - Tur-Kaspa, Ran
PY - 2000/3
Y1 - 2000/3
N2 - Giant cell hepatitis (GCH) in adults is a rare event. The diagnosis of GCH is based on findings of syncytial giant hepatocytes. It is commonly associated with either viral infection or autoimmune hepatitis type I. A patient with GCH due to autoimmune hepatitis type II (LKM1+) is described, a combination that has not been previously reported. Corticosteroid therapy was effective in decreasing serum liver enzymes; however, the patient deteriorated rapidly and developed subfulminant hepatic failure. Although an emergency orthotopic liver transplantation was performed, the patient died because of reperfusion injury. Interestingly, only a few giant hepatocytes were noted in the explanted liver. This case stresses the association of GCH with autoimmune disorders, the possible immune mechanism involved in the formation of giant cell hepatocytes, and illustrates the rapidly progressive course and unfavorable prognosis that these patients can develop. (C) 2000 by Am. Coll. of Gastroenterology.
AB - Giant cell hepatitis (GCH) in adults is a rare event. The diagnosis of GCH is based on findings of syncytial giant hepatocytes. It is commonly associated with either viral infection or autoimmune hepatitis type I. A patient with GCH due to autoimmune hepatitis type II (LKM1+) is described, a combination that has not been previously reported. Corticosteroid therapy was effective in decreasing serum liver enzymes; however, the patient deteriorated rapidly and developed subfulminant hepatic failure. Although an emergency orthotopic liver transplantation was performed, the patient died because of reperfusion injury. Interestingly, only a few giant hepatocytes were noted in the explanted liver. This case stresses the association of GCH with autoimmune disorders, the possible immune mechanism involved in the formation of giant cell hepatocytes, and illustrates the rapidly progressive course and unfavorable prognosis that these patients can develop. (C) 2000 by Am. Coll. of Gastroenterology.
UR - http://www.scopus.com/inward/record.url?scp=0034001089&partnerID=8YFLogxK
U2 - 10.1016/S0002-9270(99)00922-3
DO - 10.1016/S0002-9270(99)00922-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 10710079
SN - 0002-9270
VL - 95
SP - 799
EP - 801
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 3
ER -